Xuzhou medical university
Welcome,         Profile    Billing    Logout  
 11 Trials 
3 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cao, Jiang
BRUIN CLL-321, NCT04666038: Study of LOXO-305 Versus Investigator's Choice (IdelaR or BR) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Active, not recruiting
3
250
Europe, Canada, Japan, US, RoW
LOXO-305, Pirtobrutinib, Idelalisib, Zydelig, Bendamustine, Treanda, Treakisym, Ribomustin, Levact, Rituximab, Rituxan, MabThera, Truxima
Loxo Oncology, Inc., Eli Lilly and Company
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
08/23
05/27
NCT06593626: A Phase I Clinical Study on the Safety and Pharmacokinetics of [18F]Florbetazine Injection

Recruiting
1
28
RoW
[18F]Florbetazine
HTA Co., Ltd.
MCI, AD
09/24
09/24
NCT05907603: Research Development(RD)13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7(CD7)+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)

Recruiting
1
18
RoW
RD13-02 cell infusion
Kai Lin Xu,MD, Nanjing Bioheng Biotech Co., Ltd.
Neoplasms, Hematologic Neoplasms, Hematologic Diseases
03/24
03/25
Zheng, Junnian
No trials found

Download Options